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 The overconsumption of sugar-sweetened beverages (SSB) has frequently been targeted 
as a significant contributor to the high prevalence of overweight and obesity in the United States. 
Many American adults opt for low-calorie sweetened beverages (LCSB), such as Diet Coke, as a 
replacement. LCSB provide consumers with the sweetness of a traditional soda without the 
excessive caloric intake provided by added sugar. However, some researchers have called the use 
of LCSB into question, arguing that the consumption of LCSB may lead to weight gain rather 
than prevent it by disrupting metabolic responses, increasing one’s preference for sweet 
substances, and decreasing feelings of satiety. The purpose of this systematic review is to 
evaluate whether there is an association between the consumption of LCSB beverages and 
impact on weight among adults. The PubMed database was used to identify studies relevant to 
the research question and inclusion criteria. Seven studies satisfied the inclusion criteria and 
were included in this review. The results of the studies were assessed and summarized 
narratively. The results were inconclusive; two randomized control trials indicated a negative 
association, four randomized control trials indicated no association, and one prospective cohort 
study reported a positive association between LCSB and body weight. Possible explanations for 








 Overweight and obesity continue to jeopardize the health of American adults. Sixty-nine 
percent of adults aged 20 years or older are overweight or obese. Of these American adults, 36% 
are obese, with a body mass index (BMI) of 30 or greater (1). While the causes of overweight 
and obesity are extensive and complex, one contributing factor to the epidemic is the 
overconsumption of SSB. SSB are the single greatest contributor to excessive calorie and sugar 
intake in the average American’s diet (2). Over time, the extra calorie ingestion may contribute 
to weight gain and obesity. Thus, reducing the consumption of SSB is one of several strategies 
promoted to prevent and reduce overweight and obesity in the US adult population. 
 In an effort to reduce SSB consumption and overall caloric intake, many individuals opt 
for LCSB as a replacement. Low-calorie sweeteners, also known as artificial sweeteners or non-
nutritive sweeteners, are sugar substitutes that provide sweetness to beverages without increasing 
the calories of the drink (3). Examples of low-calorie sweeteners include aspartame, saccharin, 
and sucralose, which are often found in diet beverages, such as Diet Coke and Diet Pepsi, as well 
as sugar substitutes, such as Splenda and Sweet’n Low.  
 In recent years, the consumption of LCSB has increased among American adults. In 
2008, 24.1% of adults reported consuming beverages containing low-calorie sweeteners (3). 
Low-calorie sweeteners are viewed as a safe alternative for adding sweetness to beverages 
without adding calories that could contribute to weight gain. However, some researches have 





decrease their risk for weight gain. Instead, some suggest that LCSB consumption may 
contribute to weight gain, despite the no-calorie nature of the drink, by disrupting metabolic 
responses, increasing one’s preference for sweet substances, and decreasing feelings of satiety 
(4). The purpose of this systematic review is to evaluate whether there is an association between 








 Overweight and obesity continue to pose a significant public health problem in America, 
threatening the health and livelihood of millions of American adults. In 2014, 36% of adults in 
the United States were obese, compared to 13.4% in 1960 (1). While overweight and obesity 
affect a substantial proportion of the adult population, obesity prevalence varies by gender, race, 
and age (1, 11). Higher rates of obesity are seen among adult women than men; thirty-eight 
percent of adult women are obese compared to 34.3% of men. The rates of obesity also vary by 
race. Asian adults have significantly lower rates of obesity compared to individuals of other 
racial backgrounds. Higher rates of obesity are seen among black adults and Hispanic adults, 
compared to non-Hispanic white adults (11). Additionally, middle-aged adults have higher rates 
of obesity compared to older and younger adults. Forty percent of middle-aged adults are obese, 
compared to 37% of older adults and 32.3% of younger adults (1).  
 While evidence suggests that rates of obesity may now be stabilizing, the prevalence of 
obesity still remains high and continues to pose a public health challenge in the United States (1). 
Overweight and obesity increases one’s risk for numerous poor health outcomes.  An adult who 
is overweight or obese has an increased risk for hypertension, Type 2 diabetes, stroke, 
cardiovascular disease, gall bladder disease, and cancers, amongst other adverse physical and 
psychosocial adverse health outcomes (2). The high prevalence of overweight and obesity 
combined with the numerous adverse health outcomes from these conditions call for continued 





 Although the causes of obesity are complex, including genetic, environmental, and 
behavioral factors, the consumption of SSB has been implicated as a significant contributor to 
the high prevalence of overweight and obesity seen in today’s population. A study examining 
diet patterns and long-term weight gain found that consumption of SSB was positively associated 
with increased weight over a 4-year time frame (5). According to the Centers for Disease 
Control, 6 out of every 10 adults drink at least one SSB each day (6).  
 Not only are 60% of the adult population consuming at least one SSB each day, but the 
portion sizes of these beverages have increased significantly in recent decades. This means that 
consuming one beverage today results in a greater intake of calories than it did several decades 
ago (7). Prior to the 1950s, the standard size for a can of soda, the most common SSB, was 6.5 
ounce; this increased to the 12 ounce can in the 1960s, the 20 ounce bottle in the 1990s, and even 
large sizes found today (7). A study on changes in beverage intake from 1977 to 2001 found that 
overall caloric intake from SSB increased 135% (8). Americans consume larger portions of SSB 
and more SSB per day than in previous decades. In 1977, SSB consumption composed 2.8% of 
total caloric intake; this rose to 7.0% in 2001, which represents an increase from 50 calories to 
144 calories during this time frame (8).  
 In efforts to avoid the extra calories— and possible weight gain— that may result from 
consuming SSB, many individuals opt for replacing sugary drinks with LCSB as an alternative. 
Twenty-four percent of adults reported consuming beverages containing low-calorie sweeteners, 
including no-calorie diet beverages and calorie-reduced beverages, in 2008; this is an increase 
from 18.7% in 2000. (3). Fifteen percent of adults report consuming zero-calorie diet beverages 
sweetened with low-calorie sweeteners, with overweight and obese adults consuming more 





beverages without the added, nutrient-poor calories provided by sugar. Since LCSB provide 
virtually no additional calories to a person’s daily intake, LCSB do not directly contribute to 
weight gain. However, some researchers argue that, rather than preventing or reducing 
overweight and obesity, the consumption of LCSB may instead contribute to weight gain over 
time through indirect mechanisms, such as disrupting metabolic patterns of energy regulation, 
increasing preference for sweet substances, and decreasing satiety (4, 9).  
 Researchers who critique the consumption of LCSB point to the understanding that 
weight gain is more complicated than the simple calculation of ingested calories minus expended 
calories due to the complex metabolic pathways that contribute to changes in one’s weight. 
While LCSB provide no increased caloric intake, some suggest that the consumption of low-
calorie sweeteners may disrupt physiologic responses that are important for regulating 
metabolism. This hypothesis is based upon experiments conducted on laboratory rats (12). 
Researchers hypothesize that when an individual consumes a sweet substance, the sweetness 
level allows the body to predict the energy content (12). Consuming a substance with a sweet 
taste indicates to the body that the substance has a higher caloric content and allows the body to 
give an appropriate metabolic response. LCSB, however, provide sweet taste without the high 
caloric content that typically accompanies a sweet substance. Some researchers believe that 
disconnect between sweet taste and caloric intake provided by the consumption of LCSB has the 
possibility to disrupt energy regulation pathways, which may eventually make energy regulation 
less effective.  Researchers posit that regular consumption of low-calorie sweeteners decouples 
the relationship between sweet taste and the triggering of an appropriate metabolic response. As 
a result, this could potentially lead to less effective energy regulation, slowed metabolic 





to results from laboratory studies conducted with rodent models. Specifically, researchers found 
that rats that consumed low-calorie sweeteners consumed more calories and increased their body 
weight more than rats that consumed sugar substances (9). 
 Several studies conducted on human subjects focused on evaluating these potential 
metabolic consequences of uncoupling sweet taste and calorie content through the consumption 
of LCSB (22). In one study, subjects were instructed to consume an allotted amount of a 
beverage sweetened with a low-calorie sweetener, a beverage sweetened with sugar, or water, 
which was used as the baseline measure. Following consumption, researchers evaluated the 
subjects’ motivation to eat and food preferences. Consumers of the sugar-sweetened drink 
reported decreased motivation to eat and decreased food preferences. In comparison, consumers 
of the low-calorie sweetened drinks reported higher motivation to eat and an increase in food 
preferences following consumption. The researchers hypothesize that the low-calorie sweeteners 
may increase appetite through possible physiological mechanisms caused by stimulating sweet 
receptors (22). However, similar studies on humans have found contradictory results in which 
ingestion of LCSB did not lead to increased hunger and food intake (23).  
           In addition to the possible disruption of metabolic responses, some researchers suggest 
that the consumption of LCSB may also impact one’s psychological choices, possibly leading to 
an increased preference for sweeter and higher calorie substances at a later meal (9). In one 
experiment, participants were randomized to receive a LCSB, a SSB, or water. Following the 
consumption of the beverage, participants were given the choice between a high calorie sugary 
snack, gum, or water. Participants who consumed the LCSB were three-times more likely to 
choose the high calorie, sugary snack than participants who consumed a SSB or water. A similar 





were once again instructed to consume either a LCSB, SSB, or water. Following consumption, 
participants were permitted to eat as many cookies as they desired. Participants who consumed 
LCSB reported being less satisfied than those who consumed water or a SSB following 
consumption (9). These studies suggest that the consumption of LCSB may have an impact on an 
individual’s food regulation psychology, which could potentially lead to greater caloric intake at 
a later meal and potential weight gain. However, similar studies assessing the impact of LCSB 
on reward and food intake have found opposing findings. For example, a study evaluating the 
reward value of LCSB compared to SSB found no significant differences between the two 
beverages when analyzed through behavioral assessment and functional magnetic resonance 
imaging to assess reward responses (24). In summary, the evidence supporting the impact of 
LCSB consumption on metabolic responses and food psychology has been mixed, with some 
studies indicating possible mechanisms linking LCSB to weight gain and other studies indicating 
no potential impact on weight. 
 The objective of this systematic review is to evaluate whether there is an association 
between LCSB consumption and impact on weight. The review intends to shed light on the use 
of LCSB as an alternative to SSB consumption for preventing and controlling overweight and 








The systematic review was conducted according to the guidelines established by Khan, Kunz, 
Klejinen, and Antes in their article “Five Steps to Conducting a Systematic Review” (10).  
Framing the Question  
 The question guiding the systematic review began with the free-form research question: 
“Is there a relationship between the consumption of LCSB and impact on weight?” 
 The research question was further defined based on the population, exposures, outcome 
of interest, and study design. The population included adults of all weights, including normal, 
overweight, and obese individuals. The exposure was consumption of LCSB. The outcome of 
interest included changes in body weight and/or changes in body mass index (BMI). Acceptable 
study designs were those that compared consumers of LCSB with non-consumers in a 
prospective cohort study or randomized clinical trial. 
Inclusion and Exclusion Criteria  
 The structured research question determined which studies were included in the review. 
Studies were excluded for several reasons, as summarized in Table 1. Due to the specific focus 
on the adult population, studies assessing children or adolescent consumption of LCSB were 
excluded. Additionally, studies that focused on or included low-calorie sweetened food items 
were excluded since the research question specifically pertained to beverage consumption. 





For example, studies that analyzed LCSB consumption in relation to Type 2 diabetes, energy 
intake, and reward value were not included in the systematic review. Cross-sectional studies 
conducted at a single time point were excluded due to their inability to estimate possible weight- 
related effects over time.  
 
Table 1: Criteria for Inclusion in the Systematic Review 
Factor  Inclusion Criteria Exclusion Criteria  
Population  Adults: normal weight, 
overweight, obese  
Children/Adolescents  
Study Design Prospective cohort , randomized 
clinical trial 
Cross-sectional/descriptive studies 
Exposures Consumption of LCSB 
 
Did not include LCSB, assessed 
foods with LCS 
Outcome  Change in body weight, BMI Type 2 diabetes, reward value, 
energy intake/compensation  
 
 
Identifying Relevant Work 
 The online database PubMed was used to identify studies that were relevant to the 
research question. The following terms were used to identify articles: artificial sweetener, non-
nutritive sweeteners, low-calorie sweeteners, beverages, body weight, and body mass index. 
These terms were used in attempt to capture all possible studies pertaining to the structured 
research question.  
 The search of these terms yielded 575 hits in the PubMed database. The title and abstracts 





made according to the aforementioned criteria (Table 1). If the abstract did not provide sufficient 
information to clearly exclude the article, then the article was set aside for in-text review to 
assess whether it satisfied the inclusion criteria. Five hundred and thirty-three articles were 
excluded based on the title and abstract review, leaving 42 articles for further assessment.  
 The 42 remaining articles then underwent in-text review to assess whether they satisfied 
the criteria for inclusion in the systematic review.  Of the 42 articles, 6 were cross-
sectional/descriptive studies, 3 were prospective cohort studies, 8 were randomized control trials, 
and 25 were reviews or commentaries on the topic. The reviews and commentaries were 
evaluated to identify additional studies that may not have been captured in the PubMed search.  
 The six cross-sectional studies were excluded due to not fulfilling the study design 
criteria, which was restricted to prospective cohort studies and randomized clinical trials. Of the 
three prospective cohorts, two of them were excluded. One was excluded due to not measuring 
the outcome of body weight or BMI and the other was excluded for including consumption of 
low-calorie sweetened food.  Of the eight randomized control trials, three were excluded for not 
measuring the outcome of body weight or BMI and one was excluded for including consumption 
of low-calorie sweetened foods. An evaluation of the reviews and commentaries produced two 
additional studies, both randomized clinical trials, which were not identified in the initial 
PubMed search. 
 In total, six randomized control trials and one prospective cohort study were included in 
the systematic review. Figure 1 shows the process for selecting articles to be included in the 














   
575 articles identified 
from PubMed Search 
 
533 articles excluded based on review 
of title/ abstract  





6 cross sectional/ 
descriptive studies 
(all excluded) 
3 prospective cohorts 
(2 excluded) 
8 randomized clinical trials 
(4 excluded) 
2 randomized 
clinical trials  
1 prospective cohort  4 randomized clinical 
trials 








 In addition to meeting the inclusion criteria of population, outcome, and study designs, 
the studies included in the review were further assessed to determine their quality. The studies 
were evaluated according to the Critical Appraisal Skills Programme (CASP) checklist (20).  
Table 2 and Table 3 outline the quality assessment for the studies. The studies included in the 
systematic review were all of sufficient quality.  
Table 2: Quality Assessment of Randomized Clinical Trials 









      
Randomized       
Blinded       
Similar groups        
Equal 
treatment 
      
All subjects 
accounted for 
      
 
Table 3: Quality Assessment of Prospective Cohort Study   
Checklist Item Fowler et al 
Clearly stated research question  
Acceptable recruitment  
Accurate exposure measurement  
Accurate outcome measurement  
Identified confounders  






Summarizing Results  
 Following selection, the seven studies underwent review to assess methodology, sample 
characteristics, exposure doses, outcomes, and results. The main findings of body weight and/or 
BMI outcomes were extracted for the results of the systematic review. The results were 

















 The PubMed search resulted in seven studies that satisfied the inclusion criteria and 
where thus included in the review. Six of the studies were randomized control trials and one was 
a prospective cohort study. Table 4 summarizes the sample characteristics of each study (13-19). 
The studies ranged in sample size from 30 participants to 318 participants for the randomized 
clinical trials; the prospective cohort study had a sample of 3,371 participants. The studies varied 
by mean age, mean BMI, and sex of participants. The mean age of the samples ranged from 28 
years-old to 48-years-old.  The studies also varied by mean BMI and weight status at baseline, 
with a range of mean BMI of 22.4 to 36.3. Two randomized clinical trials examined participants 
of normal BMI (14, 16). The participants of the remaining five studies had a mean BMI that fell 
in the overweight/obese category (13, 15, 17-19). Of these studies, two of them were conducted 
in conjunction with a weight loss program for overweight/obese individuals (13, 17). 
Additionally, two of the studies explicitly focused on women (15, 16); of the other five studies, 
four of them had a larger population of women than men represented in their sample (13, 17, 18, 
19). These sample characteristics are important for understanding the results of the systematic 









Table 4: Sample Characteristics 
* indicates part of weight loss program 
**indicates prospective cohort study 
***n/a=not available 
 
 In addition to differences in sample characteristics, the studies also displayed differences 
in design. Table 5 displays the characteristics of the study designs. The duration of the 
randomized clinical trials varied from 3 weeks to 52 weeks. The prospective cohort study was 
conducted over a time period of eight years. The control groups of the studies also varied by 
substance and dose. Five of the randomized clinical trials had the participants in the comparison 
group consume SSB. In contrast, one of the randomized clinical trials had the comparison group 
consume water. While all participants in the consumer group consumed LCSB, the daily dose of 
the drink differed slightly amongst the studies. The dose ranged from 710 mL to 1200 mL of a 
LCSB per day. LCSB consumption was evaluated based on self-report method. The participants 
of the randomized clinical trials were instructed to consume the allotted servings and dose of the 
LCSB, which was provided in advance by the researchers. Compliance with the intervention was 
assessed with dietary logs and recall. In the prospective cohort study, LCSB was evaluated via 
Study Sample, n BMI, mean Sex, % Age, mean Race, % 




251 female  
48.3  58% white 
32% minority  




28.2  n/a*** 




31.7  n/a*** 




33.7  n/a*** 
Tate et al (17)*  318 36.3  
  
50 male 
268 female  
42  44% white 
54% minority  
Maersk et al (18) 47 32.1  17 male 
30 female 
38.7  n/a*** 







survey responses estimating how many LCSB the individual consumes per week. Each study 
included in the review measured change in BMI or body weight, with four studies measuring 
body weight as an outcome and three studies measuring BMI. Lastly, two randomized clinical 
trials were conducted in conjunction with a weight loss program that encouraged behavioral 
changes to aid weight loss, including increasing physical activity and improving eating habits 
(13, 17). It is important to note that the weight loss program could potentially confound the 
results and association between LCSB consumption and impact on weight. In the remaining five 
studies, the participants were not instructed to alter their eating patterns, aside the change in 
beverage consumption. 
 
Table 5: Study Characteristics 




Dose/day Outcome Main Result 





Tordoff et al 
(14) 
3 wks SSB  LCSB 1200 mL Body weight 
change 
No significant 
change in body 
weight of LCSB 
consumers  





Reid et al (16) 4 wks SSB  LCSB 1000  BMI change No significant 
change in BMI 
Tate et al (17)  26 wks SSB  LCSB 710-946 ml Body weight 
chance 
No significant 
change in body 
weight  
Maersk et al 
(18) 
26 wks   SSB LCSB 1000 mL  BMI change No significant 
change in BMI 




LCSB n/a BMI change LSCB consumers 
significantly 






 The main results of the studies are included in Table 6. Three main results were observed 
amongst the studies. First two randomized clinical trials found a statistically significant negative 
association between consumption of LCSB and body weight, one of which was conducted in 
conjunction with a weight loss program (13, 15). Second, four randomized clinical trials overall 
found no significant association between LCSB consumption and body weight (14, 16-18). 
Third, the prospective cohort study reported a significant positive association between LCSB 
consumption and body weight (19).  
 
Table 6: Results  
Study Association   Significance  Sample 
Peters et al (13) Negative P<0.0001 Overweight/obese in weight loss treatment 
program 
Reid et al (15) Negative  P<0.05 Normal weight women 
Tordoff et al (14) Negative: males 
None: females 
None overall 
P<0.05 (males) Normal weight  
Reid et al (16) None -  Overweight women 
Maersk et al (17) None -  Overweight/obese  
Tate et al (18) None -  Overweight/obese in weight loss treatment 
program  
Fowler et al (19) Positive P<0.0001 Normal, overweight, & obese in prospective 
cohort study 
 
 Looking more closely at these results, of the two studies that indicated a negative 
association between LCSB consumption and weight, one of them was conducted in combination 
with a weight loss treatment program for overweight/obese subjects (13). The study was 
assessing the effectiveness of LCSB consumption as a part of a weight loss program by 
comparing the difference between water consumption and LCSB consumption on weight loss 





better maintained the weight loss compared to subject who consumed water (P < 0.0001). The 
other study that reported a negative association between LCSB consumption and weight was 
conducted with participants of normal BMI (15). The authors note that the association between 
LCSB consumption on weight loss was statistically significant but marginal (P<0.05). In the 
study, more SSB consumers gained weight and more LCSB consumers lost weight during the 4-
week treatment period. However, when the study was repeated amongst overweight women, the 
negative association between LCSB consumption and weight was not observed (16). 
 Four studies reported no significant association between LCSB consumption and impact 
on weight when compared to consumption of SSB. Three of these studies were conducted with 
overweight/obese subjects, with one of the studies conducted as part of a weight loss treatment 
program (16, 17, 18). These three studies conducted on overweight/obese participants found no 
significant differences in body weight between the LCSB consumer group and the comparison 
group. The results of the remaining study, which evaluated the effects of LCSB consumption on 
normal-weight subjects, also study found that drinking LCSB resulted in an insignificant change 
in body weight amongst consumers. However, when the results were analyzed based on sex 
differences, the results indicated that male participants lost significantly more weight (P<0.05) 
than females, while females who consumed LCSB did not experience a significant change in 
body weight (14).  
 The results of the prospective cohort study indicated a significant positive association 
between consumption of LCSB and weight (P<0.0001). The researchers found a positive dose-
response relationship between LCSB consumption and weight gain amongst normal-weight and 
overweight/obese consumers (19). That is, the greater number of LCSB consumed per week, the 





between non-consumers and LCSB consumers in quartile 1, who consumed less than 3 LCSB 
per week (P<0.0001). The risk for overweight/obesity then continued to increase amongst LCSB 
consumers in quartile 1 to quartile 2 (3-10 LCSB per week), quartile 2 to quartile 3 (11-21 LCSB 
per week), and quartile 3 to quartile 4 (22+ LCSB per week). LCSB consumers in quartile 4, the 
highest quartile of LCSB consumption, experienced the greatest increase in BMI; individuals of 
this quartile exhibited a 78% increase in BMI compared to individuals who did not consume 









 LCSB are frequently consumed as an alternative to SSB, which have been shown to 
correlate with weight gain in American adults. Despite their no-calorie properties, some 
researchers suggest the LCSB consumption may indirectly contribute to weight gain through 
different metabolic and psychological processes. The systematic review was conducted to assess 
whether there is an association between the consumption of LCSB and impact on weight. The 
review yielded inconclusive results. No clear association was found between consumption of 
LCSB and body weight in adults. 
 A negative association was found between LCBS consumption and weight in two 
randomized clinical trials, one which was conducted during a weight loss treatment program and 
one which was conducted with individuals of normal body weight. The study conducted as a part 
of a weight loss treatment program compared LCSB consumption to water consumption (14). 
Compliance to the intervention was evaluated by reviewing daily logs of beverage intake; high 
rates of compliance were seen between both the LCSB group and water group. The results 
suggest that LCSB consumption may be an effective strategy for reducing weight when 
implemented as a part of a behavioral weight loss program for overweight/obese individuals. 
However, because the comparison group was restricted to water consumption, not SSB 
consumption, the results do not reveal whether LCSB are a suitable replacement for SSB as a 





confounded the negative association between LCSB consumption and weight, thus making it 
difficult to determine the specific impact of LCSB consumption on weight loss.  
 The other randomized clinical trial that found a negative association between LCSB 
consumption and impact on weight was conducted on normal weight women. Consumption was 
monitored using daily logs recording beverage intake during a four-week test period. The study 
reported significant but marginal effects of LCSB consumption on weight loss in comparison to 
SSB consumption, thus indicating that LCSB consumption may be beneficial for reducing 
weight gain in normal-weight women who consume SSB (15). On the other hand, when the 
study was replicated in overweight participants, no significant association was found between 
LCSB consumption and weight. (16) This finding suggests that LCSB consumption may be 
associated with decreased weight in normal-weight women, but not overweight women.  One 
possible explanation for this finding is that the factors leading to overweight may be too complex 
to be reversed by simply replacing SSB with LCSB. Assuming a normal weight individual is 
physically active and maintaining a healthy diet, replacing a SSB with a LCSB may have a 
greater impact on weight due to the likelihood of resulting in decreased caloric intake. On the 
other hand, assuming an overweight individual may not maintain a physically active lifestyle and 
balanced diet, substituting a SSB with a LCSB may not have a significant impact on weight 
because it may not be substantial enough to compensate for pre-existing poor health behaviors.  
A study found that not only are overweight/obese individuals more likely to consume LCSB 
compared to normal weight individuals, but overweight/obese individuals also consume a similar 
amount of total caloric intake compared to overweight/obese individuals who consume SSB (21). 
These results indicate that switching from SSB to LCSB is not a substantial behavior change to 





  Four randomized clinical trials reported no association between LCSB consumption and 
weight, all of which used SSB consumption as the control group. While one of the trials overall 
found no significant association between LCSB consumption and weight among normal-weight 
participants, when analyzed separately by sex, a significant negative association was observed 
among male participants during a three-week period (14). The three other studies that reported 
no association between LCSB consumption and weight were all conducted on overweight/obese 
subjects, one of which was conducted as part of a weight loss treatment program. These findings 
suggest that consuming LCSB as a replacement of SSB may not have an effect on weight 
amongst overweight and obese individuals but may have a weight-reduction effect on normal-
weight males.  
 The prospective cohort study was the only study in the systematic review to indicate a 
significant positive association between LCSB consumption and weight. The results indicate a 
positive dose-response relationship between the consumption of LCSB and weight gain. Due to 
the study design, however, the findings cannot suggest a causal relationship between LCSB and 
weight; instead, they suggest a significant correlation between LCSB consumption and increased 
weight gain in the long-term. 
 In summary, the systematic review yielded inconclusive results regarding the relationship 
between LCSB and impact on weight. A significant positive association was recorded in a 
prospective cohort study, but due to the nature of the study, causality is difficult to determine. Of 
the six randomized control trials, two studies reported a negative association and four studies 
reported no association between LCSB consumption and impact on weight. Overall, the 





through the results of this systematic review. The results of the systematic review indicate that 
there is no clear association between LCSB consumption and long-term weight gain.  
 
Limitations  
 The systematic review has several limitations. The review was conducted by a single 
evaluator. An additional researcher would have been beneficial for discussing important 
decisions throughout the process of the review, such as determining inclusion criteria, selecting 
articles, conducting the quality assessment of the research studies, and summarized the results. 
Additionally, the review was conducted using a single database, PubMed, with English language 
restrictions. This restriction could have possibly excluded eligible studies. Lastly, a meta-
analysis of the results was not performed, which could have enhanced the understanding of the 
association between LCSB consumption and impact on weight.  
 
Implications  
 The inconclusive results of the systematic review call for additional studies, specifically 
randomized clinical trials, to evaluate the relationship between LCSB consumption and impact 
on weight. A study evaluating the consumption of LCSB as a replacement of SSB in participants 
of all bodyweights would be helpful for further understanding the role of LCSB in the American 
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